AEterna Zentaris to Announce Outcome of Management's Strategic Review
September 27 2007 - 7:30AM
PR Newswire (US)
QUEBEC CITY, Sept. 27 /PRNewswire-FirstCall/ -- AEterna Zentaris
Inc. (TSX: AEZ; Nasdaq: AEZS), a global biopharmaceutical company
focused on endocrine therapy and oncology, today announced that it
will host a conference call and webcast on Tuesday, October 2, 2007
at 11:00 a.m. Eastern time regarding the outcome of management's
strategic review of the Company's pipeline and business operations.
Participants may access the live webcast via the Company's website
at http://www.aeternazentaris.com/ in the "Investors" section, or
by telephone using the following numbers: 416-644-3414,
514-807-8791 or 800-733-7571. A replay of the webcast will also be
available on the Company's website for a period of 30 days. About
AEterna Zentaris Inc. AEterna Zentaris Inc. is global
biopharmaceutical company focused on endocrine therapy and oncology
with proven expertise in drug discovery, development and
commercialization. News releases and additional information are
available at http://www.aeternazentaris.com/. DATASOURCE: AETERNA
ZENTARIS INC. CONTACT: Jenene Thomas, Senior Director, Investor
Relations & Corporate Communications, (908) 938-1475, ; Paul
Burroughs, Media Relations, (418) 652-8525 ext. 406,
Copyright